The paradox of progress: Environmental disruption of metabolism and the diabetes epidemic

Diabetes

Volumn 60, Issue 7, 2011, Pages 1838-1848

  Neel, Brian A ^a   Sargis, Robert M ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ARSENIC; CHLORPHENOTANE; DIOXIN; ENDOCRINE DISRUPTOR; FURAN DERIVATIVE; HEXACHLOROBENZENE; HEXACHLOROCYCLOHEXANE; HEXACHLORODIBENZO 4 DIOXIN; HIGHER CHLORINATED DIOXIN; INSULIN; MONO(2 ETHYL 5 OXOHEXYL)PHTHALIC ACID; ORGANOCHLORINE PESTICIDE; PESTICIDE; PHTHALIC ACID BUTYL ESTER; PHTHALIC ACID ESTER; PHTHALIC ACID ETHYL ESTER; PHTHALIC ACID MONOBENZYL ESTER; PLASTICIZER; POLYBROMINATED BIPHENYL; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; UNCLASSIFIED DRUG; CELL RECEPTOR; GLUCOSE; XENOBIOTIC AGENT;

BIOACCUMULATION; CALORIC INTAKE; DIABETES MELLITUS; DIABETOGENESIS; ENERGY EXPENDITURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIC; EPIGENETICS; FISH; FOOD CONTAMINATION; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INSULIN RELEASE; MEDICAL RESEARCH; METABOLIC DISORDER; NONHUMAN; OBESITY; ORGANIC POLLUTION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; POLLUTANT; PRIORITY JOURNAL; REVIEW; SEA FOOD; ANIMAL; ANIMAL MODEL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETIC EPIGENESIS; HOMEOSTASIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GLUCOSE; HOMEOSTASIS; HUMANS; MODELS, ANIMAL; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; XENOBIOTICS;

EID: 80052084488     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0153     Document Type: Review

References (75)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
2. American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 2008;31:596-615
3. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrinedisrupting chemicals in wildlife and humans. Environ Health Perspect 1993;101:378-384
4. Environmental Protection Agency. Special Report on Environmental Endocrine Disruption: An Effects Assessment and Analysis. Washington, D.C., U.S. Environmental Protection Agency, 1997
5. Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 2011;73:135-162
6. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241
7. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002;8:185-192
8. Grün F, Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol 2009;304:19-29
9. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624
10. Bertazzi PA, Consonni D, Bachetti S, et al. Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 2001;153:1031-1044
11. Wang SL, Tsai PC, Yang CY, Leon Guo Y. Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diabetes Care 2008;31:1574-1579
12. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 1997;8:252-258
13. Beard J, Sladden T, Morgan G, Berry G, Brooks L, McMichael A. Health impacts of pesticide exposure in a cohort of outdoor workers. Environ Health Perspect 2003;111:724-730
14. Calvert GM, Sweeney MH, Deddens J, Wall DK. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 1999;56:270-276
15. Turyk M, Anderson H, Knobeloch L, Imm P, Persky V. Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers. Environ Health Perspect 2009;117:1076-1082
16. Ukropec J, Radikova Z, Huckova M, et al. High prevalence of prediabetes and diabetes in a population exposed to high levels of an organochlorine cocktail. Diabetologia 2010;53:899-906
17. Lai MS, Hsueh YM, Chen CJ, et al. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994;139:484-492
18. Jørgensen ME, Borch-Johnsen K, Bjerregaard P. A cross-sectional study of the association between persistent organic pollutants and glucose intolerance among Greenland Inuit. Diabetologia 2008;51:1416-1422
19. Lim JS, Lee DH, Jacobs DR Jr. Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population, 2003-2004. Diabetes Care 2008;31:1802-1807
20. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 2007;115:876-882
21. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Atlanta, GA, Centers for Disease Control and Prevention, 2010
22. Lee DH, Lee IK, Song K, et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006;29:1638-1644
23. National Health and Nutrition Examination Survey. NHANES 2003-2004 Laboratory Files. Atlanta, GA, Centers for Disease Control and Prevention, 2010
24. Lang IA, Galloway TS, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008;300:1303-1310
25. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 2006;114:106-112
26. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 2008;3:e2069
27. Alonso-Magdalena P, Ropero AB, Soriano S, Quesada I, Nadal A. Bisphenol-A: a new diabetogenic factor? Hormones (Athens) 2010;9:118-126
28. Hoppe AA, Carey GB. Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity (Silver Spring) 2007;15:2942-2950
29. Gayathri NS, Dhanya CR, Indu AR, Kurup PA. Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. Indian J Med Res 2004;119:139-144
30. Zuo Z, Chen S, Wu T, et al. Tributyltin causes obesity and hepatic steatosis in male mice. Environ Toxicol 2011;26:79-85
31. Ruzzin J, Petersen R, Meugnier E, et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 2010;118:465-471
32. Liu PC, Matsumura F. Differential effects of 2,3,7,8-tetrachlorodibenzop- dioxin on the "adipose- type" and "brain-type" glucose transporters in mice. Mol Pharmacol 1995;47:65-73
33. Sato S, Shirakawa H, Tomita S, et al. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol Appl Pharmacol 2008;229:10-19
34. Remillard RB, Bunce NJ. Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 2002;110:853-858
35. Nishiumi S, Yoshida M, Azuma T, Yoshida K, Ashida H. 2,3,7,8- tetrachlorodibenzo-p-dioxin impairs an insulin signaling pathway through the induction of tumor necrosis factor-alpha in adipocytes. Toxicol Sci 2010;115:482-491
36. Fried KW, Guo GL, Esterly N, Kong B, Rozman KK. 2,3,7,8- tetrachlorodibenzop-dioxin (TCDD) reverses hyperglycemia in a type II diabetes mellitus rat model by a mechanism unrelated to PPAR gamma. Drug Chem Toxicol 2010;33:261-268
37. Weber LW, Lebofsky M, Stahl BU, Gorski JR, Muzi G, Rozman K. Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology 1991;66:133-144
38. Takeda K, Toda K, Saibara T, et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 2003;176:237-246
39. Bryzgalova G, Gao H, Ahren B, et al. Evidence that oestrogen receptoralpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006;49:588-597
40. Jones TH, Arver S, Behre HM, et al. TIMES2 Investigators. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828-837
41. Eisner JR, Dumesic DA, Kemnitz JW, Abbott DH. Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys. J Clin Endocrinol Metab 2000;85:1206-1210
42. Kandaraki E, Chatzigeorgiou A, Livadas S, et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab 2011;96:E480-E484
43. Urbatzka R, van Cauwenberge A, Maggioni S, et al. Androgenic and antiandrogenic activities in water and sediment samples from the river Lambro, Italy, detected by yeast androgen screen and chemical analyses. Chemosphere 2007;67:1080-1087
44. Jugan ML, Levi Y, Blondeau JP. Endocrine disruptors and thyroid hormone physiology. Biochem Pharmacol 2010;79:939-947
45. Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr, Mainous AG 3rd. Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 2007;103:413-418
46. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 2010;18:1283-1288
47. Atanasov AG, Tam S, Röcken JM, Baker ME, Odermatt A. Inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates. Biochem Biophys Res Commun 2003;308:257-262
48. Atanasov AG, Nashev LG, Tam S, Baker ME, Odermatt A. Organotins disrupt the 11beta-hydroxysteroid dehydrogenase type 2-dependent local inactivation of glucocorticoids. Environ Health Perspect 2005;113:1600-1606
49. Grün F, Watanabe H, Zamanian Z, et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 2006;20:2141-2155
50. Kirchner S, Kieu T, Chow C, Casey S, Blumberg B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol Endocrinol 2010;24:526-539
51. Hanlon PR, Ganem LG, Cho YC, Yamamoto M, Jefcoate CR. AhR- and ERK-dependent pathways function synergistically to mediate 2,3,7,8- tetrachlorodibenzo-p-dioxin suppression of peroxisome proliferator-activated receptor-gamma1 expression and subsequent adipocyte differentiation. Toxicol Appl Pharmacol 2003;189:11-27
52. Moreau A, Vilarem MJ, Maurel P, Pascussi JM. Xenoreceptors CAR and PXR activation and consequences on lipid metabolism, glucose homeostasis, and inflammatory response. Mol Pharm 2008;5:35-41
53. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005;308:1466-1469
54. Anway MD, Leathers C, Skinner MK. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 2006;147:5515-5523
55. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009;58:2718-2725
56. Wang J, Lv X, Du Y. Inflammatory response and insulin signaling alteration induced by PCB77. J Environ Sci (China) 2010;22:1086-1090
57. Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 2009;304:49-54
58. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 2011;50:567-575
59. Lu TH, Su CC, Chen YW, et al. Arsenic induces pancreatic beta-cell apoptosis via the oxidative stress-regulated mitochondria-dependent and endoplasmic reticulum stress-triggered signaling pathways. Toxicol Lett 2011;201:15-26
60. Au WW, Sierra-Torres CH, Cajas-Salazar N, Shipp BK, Legator MS. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Perspect 1999;107:501-505
61. Fujiyoshi PT, Michalek JE, Matsumura F. Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S. Air force veterans of the Vietnam war. Environ Health Perspect 2006;114:1677-1683
62. Vandenberg LN, Maffini MV, Sonnenschein C, Rubin BS, Soto AM. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009;30:75-95
63. Feige JN, Gerber A, Casals-Casas C, et al. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPAR-alpha-dependent mechanisms. Environ Health Perspect 2010;118:234-241
64. Heindel JJ, vom Saal FS. Meeting report: batch-to-batch variability in estrogenic activity in commercial animal diets-importance and approaches for laboratory animal research. Environ Health Perspect 2008;116:389-393
65. Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet. Atlanta, GA, Centers for Disease Control and Prevention, 2011
66. Espelt A, Borrell C, Roskam AJ, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century. Diabetologia 2008;51:1971-1979
67. Quintero-Somaini AQM. Hidden Danger: Environmental Health Threats in the Latino Community. National Resources Defense Council, Ed. Washington, DC, National Resources Defense Council, 2004
68. Cox S, Niskar AS, Narayan KM, Marcus M. Prevalence of self-reported diabetes and exposure to organochlorine pesticides among Mexican Americans: Hispanic health and nutrition examination survey, 1982-1984. Environ Health Perspect 2007;115:1747-1752
69. Codru N, Schymura MJ, Negoita S, Rej R, Carpenter DO; Akwesasne Task Force on Environment. Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult Native Americans. Environ Health Perspect 2007;115:1442-1447
70. Brulle RJ, Pellow DN. Environmental justice: human health and environmental inequalities. Annu Rev Public Health 2006;27:103-124
71. Carson R. Silent Spring. New York, Houghton Mifflin, 1962
72. U.S. Tariff Commission, Ed. Synthetic Organic Chemicals: United States Production and Sales. Washington, DC, Government Printing Office; 1939-1994
73. Gains beat losses. In Chemical & Engineering News. Washington, DC, American Chemical Society, 2000, p. 50-56
74. Output Declines in U.S. Europe. In Chemical & Engineering News. Washington, DC, American Chemical Society, 2010, p. 54-62
75. Centers for Disease Control and Prevention, Ed. Long-term Trends in Diabetes. Atlanta, GA, 2009